Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Rapaccini

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
European Review for Medical and Pharmacological Sciences|July 8, 2016
An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchymaM Giuga, A M De Gaetano, A Guerra, et al.
Journal of Crohn'S & Colitis|June 8, 2012
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressantsG Andrisani, D Frasca, M Romero, et al.
La Radiologia Medica|January 30, 2013
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE)R Iezzi, V Cesario, L Siciliani, et al.
Alimentary Pharmacology & Therapeutics|August 4, 2015
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up studyD Pugliese, L Guidi, P M Ferraro, et al.
European Review for Medical and Pharmacological Sciences|October 25, 2019
Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disordersU Basile, C Napodano, K Pocino, et al.
Abdominal Imaging|September 19, 2012
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imagingA Gatto, A M De Gaetano, M Giuga, et al.
European Review for Medical and Pharmacological Sciences|December 30, 2020
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: a pilot studyU Basile, L Miele, C Napodano, et al.
Oncology|April 15, 1999
Gross pathologic types of hepatocellular carcinoma in ItalyT Stroffolini, P Andreone, A Andriulli, et al.
Journal of Hepatology|January 6, 1999
Characteristics of hepatocellular carcinoma in ItalyT Stroffolini, P Andreone, A Andriulli, et al.
European Review for Medical and Pharmacological Sciences|June 8, 2019
A novel biomarker score for the screening and management of patients with plasma cell proliferative disordersU Basile, F Gulli, M A Isgrò, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
European Review for Medical and Pharmacological Sciences|July 8, 2016
An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchymaM Giuga, A M De Gaetano, A Guerra, et al.
Journal of Crohn'S & Colitis|June 8, 2012
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressantsG Andrisani, D Frasca, M Romero, et al.
La Radiologia Medica|January 30, 2013
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE)R Iezzi, V Cesario, L Siciliani, et al.
Alimentary Pharmacology & Therapeutics|August 4, 2015
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up studyD Pugliese, L Guidi, P M Ferraro, et al.
European Review for Medical and Pharmacological Sciences|October 25, 2019
Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disordersU Basile, C Napodano, K Pocino, et al.
Abdominal Imaging|September 19, 2012
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imagingA Gatto, A M De Gaetano, M Giuga, et al.
European Review for Medical and Pharmacological Sciences|December 30, 2020
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: a pilot studyU Basile, L Miele, C Napodano, et al.
Oncology|April 15, 1999
Gross pathologic types of hepatocellular carcinoma in ItalyT Stroffolini, P Andreone, A Andriulli, et al.
Journal of Hepatology|January 6, 1999
Characteristics of hepatocellular carcinoma in ItalyT Stroffolini, P Andreone, A Andriulli, et al.
European Review for Medical and Pharmacological Sciences|June 8, 2019
A novel biomarker score for the screening and management of patients with plasma cell proliferative disordersU Basile, F Gulli, M A Isgrò, et al.
Pageof 9